Literature DB >> 1855980

Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival.

A K Franks1, K I Kujawa, L J Yaffe.   

Abstract

Tumor necrosis factor alpha (TNF) is thought to play a major role in the pathogenesis of septic shock. Anti-TNF antibody was preadministered in low-dose endotoxin lethality models in which BALB/c mice were challenged with small amounts of lipopolysaccharide following their sensitization with either carrageenan (CAR) or D-galactosamine (D-GalN). Although the antibody virtually eliminated circulating TNF in both the CAR and the D-GalN models, only the D-GalN model mice were afforded survival, adding to a growing body of evidence that substances other than TNF play a key role in endotoxin-induced lethality. Further examination of sera from these mice showed a much greater elevation of interleukin-6 levels in the CAR-sensitized group than in the D-GalN-sensitized group.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855980      PMCID: PMC258063          DOI: 10.1128/iai.59.8.2609-2614.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Oxpentifylline in endotoxaemia.

Authors:  P Zabel; D T Wolter; M M Schönharting; U F Schade
Journal:  Lancet       Date:  1989 Dec 23-30       Impact factor: 79.321

2.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Carrageenan and delayed hypersensitivity. II. Activation of Hageman factor by carrageenan and its possible significance.

Authors:  H J Schwartz; R W Kellermeyer
Journal:  Proc Soc Exp Biol Med       Date:  1969-12

Review 4.  Lymphotoxin.

Authors:  N L Paul; N H Ruddle
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

5.  Cytokine regulation of interleukin 6 production by human endothelial cells.

Authors:  M R Shalaby; A Waage; T Espevik
Journal:  Cell Immunol       Date:  1989-07       Impact factor: 4.868

6.  Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection.

Authors:  D C Helfgott; S B Tatter; U Santhanam; R H Clarick; N Bhardwaj; L T May; P B Sehgal
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

7.  Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.

Authors:  E Girardin; G E Grau; J M Dayer; P Roux-Lombard; P H Lambert
Journal:  N Engl J Med       Date:  1988-08-18       Impact factor: 91.245

8.  Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.

Authors:  A Waage; T Espevik
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

9.  Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.

Authors:  A S Cross; J C Sadoff; N Kelly; E Bernton; P Gemski
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

10.  Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma.

Authors:  P Brouckaert; D R Spriggs; G Demetri; D W Kufe; W Fiers
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  14 in total

1.  Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling.

Authors:  Roxanna A Irani; Yujin Zhang; Cissy Chenyi Zhou; Sean C Blackwell; M John Hicks; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2010-03-29       Impact factor: 10.190

2.  Protective effects of a leukotriene inhibitor and a leukotriene antagonist on endotoxin-induced mortality in carrageenan-pretreated mice.

Authors:  M Ogata; T Matsumoto; M Kamochi; S I Yoshida; Y Mizuguchi; A Shigematsu
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice.

Authors:  F Amiot; C Fitting; K J Tracey; J M Cavaillon; F Dautry
Journal:  Mol Med       Date:  1997-12       Impact factor: 6.354

4.  Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice.

Authors:  K Takashima; K Tateda; T Matsumoto; Y Iizawa; M Nakao; K Yamaguchi
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

5.  Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice.

Authors:  P Matthys; T Mitera; H Heremans; J Van Damme; A Billiau
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

6.  Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model.

Authors:  B E Barton; J V Jackson
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

7.  Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies.

Authors:  C R Amura; R Silverstein; D C Morrison
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  Immunological priming attenuates the in vivo pathophysiological response to lipopolysaccharide. Comparison of cytokine production, tissue injury, and lethality in complete Freund's adjuvant-primed mice and in unprimed mice.

Authors:  L E DeForge; E Takeuchi; D T Nguyen; D G Remick
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

9.  Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection.

Authors:  G Teti; G Mancuso; F Tomasello
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

10.  Inhibition of tumor necrosis factor-alpha action within the CNS markedly reduces the plasma adrenocorticotropin response to peripheral local inflammation in rats.

Authors:  A V Turnbull; F J Pitossi; J J Lebrun; S Lee; J C Meltzer; D M Nance; A del Rey; H O Besedovsky; C Rivier
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.